Magnesium bisglycinate
Magnesium bisglycinate is a chelated form in which magnesium is bound to two glycine molecules. It is used in the “recovery” field because magnesium participates in hundreds of enzymatic reactions (energy, neuromuscular function, protein synthesis) and because some chelated forms are often better tolerated at the gastrointestinal level than more osmotically active salts.
Magnesium chelate with glycine: a formulation focused on tolerability and recovery support
Magnesium bisglycinate is a chelated form in which magnesium is bound to two glycine molecules. It is used in the “recovery” context because magnesium is involved in hundreds of enzymatic reactions (energy, neuromuscular function, protein synthesis) and because some chelated forms are often better tolerated at the gastrointestinal level than salts that are more osmotically active.
Mechanism of action
Magnesium acts mainly as a cofactor and ionic modulator: (1) it stabilizes ATP and makes it biologically active (Mg-ATP), influencing glycolysis, oxidative phosphorylation, and muscle contraction; (2) it modulates ion channels and receptors (e.g. physiological calcium antagonism in some contexts), contributing to neuromuscular excitability and relaxation; (3) it participates in mitochondrial function and protein synthesis; (4) it contributes to the regulation of the stress-response axis and neurotransmission (with indirect effects on sleep and the perception of fatigue). The bisglycinate form is intended to deliver Mg2+ in a way that is more “neutral” for the intestine than more laxative salts, reducing the osmotic draw of water into the lumen.
Supported benefits
- Correction or improvement of parameters related to magnesium deficiency (e.g. cramps/neuromuscular irritability in deficient individuals, normalization of magnesium status markers) (strong)
- Improved sleep quality in specific populations (especially older adults or individuals with low magnesium intake/status), with variable outcomes across studies (moderate)
- Reduction in blood pressure in individuals with elevated blood pressure or cardiometabolic risk (small-to-moderate average effect; depends on dose, duration, and baseline status) (moderate)
- Reduction in migraine frequency/intensity for prevention in some individuals (more evidence for magnesium in general; the specific form may vary) (moderate)
- Support for perceived recovery and muscle function in athletes/active individuals when intake is insufficient (heterogeneous evidence; benefits are more likely in deficiency) (limited)
Safety & side effects
- Gastrointestinal disturbances (nausea, abdominal cramps, diarrhea): generally less frequent with chelates than with more laxative salts, but possible
- Drowsiness or perceived relaxation in some individuals (not universal)
- Rarely: hypermagnesemia in cases of kidney impairment or excessive use (it may present with weakness, hypotension, confusion, arrhythmias)
FAQ
Is magnesium bisglycinate “better” than citrate or oxide?
“Better” depends on the goal. Oxide often has lower bioavailability and more laxative effects for the same amount of elemental magnesium. Citrate and chelates tend to be more bioavailable and/or better tolerated. Bisglycinate is often chosen for tolerability; individual differences and the dose per serving matter a great deal.
Why is it associated with recovery?
Magnesium is involved in energy production (Mg-ATP), neuromuscular function, and sleep quality. If intake is insufficient, restoring it may improve factors that influence recovery (fatigue, cramps, sleep). In the absence of insufficiency, the additional effect may be small or nonexistent.
How should the dosage on the label be interpreted?
It is essential to distinguish between “mg of elemental magnesium” and “mg of compound” (bisglycinate). Labels may report both; elemental magnesium is used to compare products and studies.
Does magnesium really help with cramps?
The evidence is mixed: some cramps are related to neuromuscular fatigue, hydration/electrolytes, or other causes not resolved by magnesium. The benefit is more plausible when a deficiency or increased losses are present.
Are there signs of excess to watch for?
The most common signs of excess from supplements are diarrhea and abdominal cramps. Systemic signs (marked weakness, hypotension, confusion, slow/irregular heartbeat) require medical attention, especially if kidney function is reduced.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use should be evaluated and authorized by a qualified healthcare professional.
Mechanism of action
Magnesium acts primarily as a cofactor and ionic modulator: (1) it stabilizes and makes ATP biologically active (Mg-ATP), influencing glycolysis, oxidative phosphorylation, and muscle contraction; (2) it modulates ion channels and receptors (e.g. physiological calcium antagonism in certain contexts), contributing to neuromuscular excitability and relaxation; (3) it participates in mitochondrial function and protein synthesis; (4) it contributes to the regulation of the stress-response axis and neurotransmission (with indirect effects on sleep and perception of fatigue). The bisglycinate form is intended to deliver Mg2+ in a way that is more “neutral” for the intestine compared with more laxative salts, reducing the osmotic draw of water into the lumen.
Scientific benefits
Contraindications
- Moderate-to-severe renal insufficiency or reduced renal function not assessed (risk of magnesium accumulation)
- Known hypermagnesemia
- Heart blocks or conditions in which excess magnesium may worsen conduction (clinical evaluation required)
- Concomitant use of laxatives/high-dose magnesium salts (risk of excess and diarrhea)
Side effects
- Gastrointestinal disturbances (nausea, abdominal cramps, diarrhea): generally less frequent with chelates than with more laxative salts, but possible
- Drowsiness or perceived relaxation in some individuals (not universal)
- Rarely: hypermagnesemia in cases of renal insufficiency or excessive use (may present with weakness, hypotension, confusion, arrhythmias)
Interactions
- Tetracycline and fluoroquinolone antibiotics: magnesium can chelate the drug and reduce its absorption; temporal separation is often recommended
- Levothyroxine: minerals can reduce its absorption; temporal separation is often necessary
- Bisphosphonates: possible reduction in absorption if taken together
- Diuretics (loop and thiazide): may increase magnesium losses; others (potassium-sparing) may alter electrolytes; professional evaluation is required
- Proton pump inhibitors (chronic use): associated with hypomagnesemia in some cases; supplementation should be assessed in the clinical context
- Drugs that depress neuromuscular conduction or sedatives: potential additive effects in sensitive individuals (variable clinical relevance)
Regulatory status
In the EU/Italy, magnesium (in various forms, including chelates) is commonly authorized as an ingredient for food supplements under applicable regulations; health claims must comply with Reg. (EC) 1924/2006 and the lists of authorized claims. It is not in itself a doping substance; it remains subject to manufacturer quality/contaminant controls.
Supplements and peptides
RecoveryBcaa
BCAAs (branched-chain amino acids) are three essential amino acids—leucine, isoleucine, and valine—particularly…
RecoveryComplete electrolytes
“Complete electrolytes” refers to formulations that mainly combine sodium (Na+), potassium (K+), chloride (Cl−),…
RecoveryEAA (essential amino acids)
EAAs (Essential Amino Acids) are the 9 amino acids that the human body cannot synthesize in sufficient quantities and…